dapagliflozin - Generic mfg.
doxorubicin hydrochloride - Generic mfg.
Januvia (sitagliptin) - Merck (MSD)
SGLT2i/DPPi: Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC (clinicaltrials.gov) - Oct 16, 2026 - P4 | N=150 | Recruiting | Sponsor: Tanta University | Not yet recruiting ➔ Recruiting 
Enrollment open • Breast Cancer • Cardiovascular • Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT07436663
 
Oct 16, 2026
 
Prev Next